A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2929 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

NCT03429673

Non-small Cell Lung Cancer

COMPLETED

A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

NCT03427567

Non-small Cell Lung Cancer

COMPLETED

A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies

NCT03421093

Lung Cancer

COMPLETED

A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

NCT03429192

Non-small Cell Lung Cancer

COMPLETED

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

NCT03427541

Non Small Cell Lung Cancer

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial is a multi-centre real-world non-interventional observational study. The Chinese patients with N2 non-small cell lung cancer enrolled from 2014 to 2017 who received radical resections of lung cancer and adjuvant chemotherapies will be included in the study and the study data on patient demographic/tumor biological characteristics and clinical treatment will be collected to evaluate compare effectiveness of radical resection of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies after surgeries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgeries+adjuvant chemotherapies

Patients who received radical resection of lung cancer + adjuvant chemotherapies

Surgeries

Intervention Type PROCEDURE

Surgeries plus adjuvant chemotherapies or perioperative chemotherapies

Perioperative chemotherapies

Patients who received perioperative chemotherapies

Surgeries

Intervention Type PROCEDURE

Surgeries plus adjuvant chemotherapies or perioperative chemotherapies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgeries

Surgeries plus adjuvant chemotherapies or perioperative chemotherapies

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Adjuvant chemotherapies or perioperative chemotherapies

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with radical resection of lung cancer enrolled from 2014 to 2019;
* Pathologically diagnosed patients with non-small cell lung cancer;
* Patients with age \> 18 years old;
* Patients who did not receive chest surgeries before hospitalization;
* Patients with N2 lymph nodes (+) after surgeries;
* Patients who received lymphadenectomy for one group or more groups of lymph nodes;